CPC A61K 8/11 (2013.01) [A61K 6/20 (2020.01); A61K 6/69 (2020.01); A61K 6/71 (2020.01); A61K 8/19 (2013.01); A61K 8/21 (2013.01); A61K 8/24 (2013.01); A61K 8/64 (2013.01); A61K 8/87 (2013.01); A61K 9/0056 (2013.01); A61K 9/5031 (2013.01); A61K 9/5089 (2013.01); A61K 33/06 (2013.01); A61K 33/16 (2013.01); A61K 33/44 (2013.01); A61K 47/02 (2013.01); A61Q 3/02 (2013.01); A61Q 5/02 (2013.01); A61Q 5/06 (2013.01); A61Q 5/12 (2013.01); A61Q 11/00 (2013.01); A61Q 13/00 (2013.01); A61Q 17/005 (2013.01); A61Q 17/02 (2013.01); A61Q 19/00 (2013.01); A61K 2300/00 (2013.01); A61K 2800/412 (2013.01); A61K 2800/56 (2013.01)] | 20 Claims |
1. A composition comprising a plurality of first microcapsules and a plurality of second microcapsules, said plurality of first microcapsules comprising a polymer substantially disposed as a semipermeable shell around a positively charged ion and said plurality of second microcapsules comprising a polymer substantially disposed as a semipermeable shell around a negatively charged ion in said plurality of second microcapsules, wherein each of the positively charged ion and the negatively charged ion permeate the semipermeable shell, and wherein the composition is suitable for delivery to a mammal.
|